The researchers found that patients with poorly controlled severe asthma generated significantly higher CO2 emissions (5.2% to 23.0% more) due to increased hospitalizations and overuse of rescue inhalers, particularly short-acting bronchodilators. However, when patients were referred to specialist asthma care, their carbon emissions decreased by 12.1% to 23.9%, demonstrating that better asthma management not only improves patient health but also reduces environmental impact

This study identifies key factors that define good mental health for people with intellectual disabilities, highlighting the importance of a supportive environment, communication, and social contacts over productivity. The findings provide a basis for developing accessible mental health promotion campaigns and programs that involve individuals with intellectual disabilities, their caregivers, and professionals to enhance health equity and inclusion.

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by discussing the multifactorial influences that contribute to Alzheimer's Disease progression.

This study investigated the prevalence and impact of auditory agnosia for environmental sounds in individuals with Alzheimer’s disease (AD), finding that over half exhibited signs of this central auditory dysfunction along with a high rate of unrecognized peripheral hearing loss. Although these factors appeared independent and showed limited direct effect on measured quality of life, possibly due to sheltered living environments and lack of patient awareness, they jointly contribute to daily functional decline, highlighting the importance of early hearing assessment and intervention in AD management.

The article discusses the need for and challenges of developing combination therapies for Alzheimer's disease, given the complex and multifactorial nature of the disease. As of 2024, there were 21 combination trials in the pipeline, primarily involving repurposed agents targeting processes like inflammation, senescence, and amyloid-tau interactions. Key challenges include distinguishing individual drug effects and managing the operational complexity of combination trials.f

This article provides a narrative review of the relationships between modifiable lifestyle factors and plasma biomarkers of Alzheimer's disease (AD). The key findings are that better nutrition, more physical activity, and good sleep quality are associated with more favorable plasma AD biomarker profiles, potentially reflecting less cerebral AD pathology.